Home Add to Favorite Contact Submit  
           25 October, 2020

Category:  Press » Society


Study Evaluating Novel Combination of nab-paclitaxel and capecitabine for 1st Line Treatment of Metastatic Breast Cancer Presented at the American Society of Clinical Oncology Annual Meeting

         Views: 1260
2007-06-03 09:23:55     
The West Clinic

Researchers from The West Clinic, the Mid-South's premier provider of interdisciplinary cancer care, and ACORN (Accelerated Community Oncology Research Network) today announced results from a Phase II study evaluating nanoparticle albumin bound (nab(TM)) -paclitaxel (ABRAXANE(R)) with capecitabine (Xeloda(R)) in a novel first-line combination treatment for patients with metastatic breast cancer at the 43rd Annual Meeting of the American Society of Clinical Oncology (ASCO). The study demonstrated that nab-paclitaxel in combination with capecitabine resulted in a 61 percent overall tumor response rate and was well tolerated.

"Both therapies have shown substantial single-agent activity for the treatment of metastatic breast cancer," said Principal Investigator Lee S. Schwartzberg, M.D., The West Clinic. "The results of the study demonstrate that nab-paclitaxel and capecitabine, in combination, are very active and well tolerated as a first-line treatment suggesting a need for further comparative research of this novel combination."

Final results from the study "Phase II trial of nab(TM)-paclitaxel nanoparticle albumin-bound paclitaxel + capecitabine in first line treatment of metastatic breast cancer" (Abstract 1053) were presented in a poster by lead author Bradley G. Somer M.D. of The West Clinic. The multicenter, open label single-arm study of 50 patients was designed to evaluate the safety and efficacy of nab-paclitaxel with capecitabine in a novel dosing regimen for the first-line treatment of metastatic breast cancer. The primary endpoint of the study was tumor response rate, with an evaluation performed after every 2 cycles.

Patients were administered nab-paclitaxel 125 mg/m2 intravenously on day 1, 8 and with no premedication and capecitabine 825 mg/m2 prescribed orally twice a day, on days 1-14 on an every three week cycle. This novel combination demonstrated a 57 percent (n=26) partial response and 4 percent complete response (n=2), with a median progression free survival of 270 days in an evaluable population of 46 enrolled patients. Four patients were inevaluable due to adverse events (n=3) and brain metastases (n=1).

Most frequently reported Grade 3-4 adverse events included fatigue (n=4), hand foot syndrome (n=3), mucositis (n=3), nausea/vomiting (n=2), febrile neutropenia (n=2) and neutropenia (n=1). Dose reductions and delays were uncommon.

This research was supported by Abraxis BioScience, Inc. and Roche.

About Breast Cancer

According to the American Cancer Society, breast cancer is the most common cancer among women, other than skin cancer, and is the second leading cause of cancer death in women in the United States. The risk of having breast cancer for a woman sometime during her life is about one in eight. In 2007 alone, an estimated 178,480 new cases of breast cancer are expected to occur in women, and an estimated 40,460 women are expected to die from the disease.

About The West Clinic

The West Clinic is the Mid-South's premier provider of interdisciplinary cancer care with specialty providers in medical oncology, hematology, gynecologic oncology, diagnostic radiology, interventional radiology, endocrinology, rheumatology, pain & palliative care, internal medicine, and psychology throughout clinics located in Memphis, the Mid-South, and North Mississippi.

Accelerated Community Oncology Research Network, Inc. (ACORN)

The ACORN network includes over 30 progressive community oncology practices located throughout the U.S. and in Singapore. This collaboration of select community oncology clinics provides patients with access to the most promising clinical trials available anywhere. By employing the ACORN centralized model of efficiency and advanced technology, ACORN network members enjoy the advantage of a quicker and more efficient research process. By linking like-minded practices in a cooperative network, ACORN consistently meets accrual objectives and delivers quality data collection.

Lee Schwartzberg, M.D., F.A.C.P.

Dr. Lee Schwartzberg is a senior partner and Medical Director at The West Clinic in Memphis, Tennessee. He did a residency in Internal Medicine at Cornell University and fellowship training in Hematology and Oncology at Memorial Sloan-Kettering Cancer Center where he was chief resident in Medicine.

Dr. Schwartzberg is board certified in Internal Medicine, Medical Oncology and Hematology. He is a Clinical Professor of Medicine at The University of Tennessee College of Medicine. Dr. Schwartzberg serves as the Medical Director of the Baptist Centers for Cancer Care Stem Cell Transplant Program and Cancer Genetics Program at Baptist Memphis Hospital. He is President of the Accelerated Community Oncology Research Network (ACORN) and Chief Medical Officer of Supportive Oncology Services (SOS).

Dr. Schwartzberg has published numerous papers in peer-reviewed publications and has lectured extensively throughout the United States and internationally. He also serves as Editor-in-Chief of the journal Community Oncology. Dr. Schwartzberg serves as a committee member on the Institute of Medicine's (IOM) Committee on Psychosocial Services to Cancer Patients/Families.

Bradley G. Somer, M.D.

Dr. Brad Somer is a board certified Medical Oncologist with The West Clinic. Dr. Somer obtained his medical degree from the Albert Einstein College of Medicine with a "Distinction in Research". He completed his fellowship training at the University of Pennsylvania Cancer Center and internship and residency at the Hospital University of Pennsylvania in Philadelphia. Dr. Somer leads the clinical guideline process of The West Clinic and is actively involved in research as principal investigator of several research trials at The West Clinic and the Accelerated Community Oncology Research Network (ACORN).

Specialized in: Trials - Clinical - Dictionary - Drug
URL: http://www.westclinic.com
Print press release      Bookmark this page
Related Press releases 
Give Dad Gifts He Really Wants This Father's Day, Says notonthehighstreet.com (Popularity: ): With Father's Day fast approaching -- it falls on Sunday 20 June -- notonthehighstreet.com is today promoting its extensive range of Father's day gifts to family members looking to get dad something different they can really enjoy.Following research conducted by Wakefield Research on behalf of Western Union, nearly half of fathers said they had pretended to like a Father's Day gift they received. Of the fathers who responded to the ...
Los Angeles is Largest City to Partner With RecycleBank (Popularity: ): Mayor Antonio R. Villaraigosa announced today that the City of Los Angeles has partnered with RecycleBank®, an incentive program that rewards households for Blue Bin recycling. The program, which is being made available without charge as a pilot to 15,000 single family homes along selected routes in the West Valley and North Central sections of the city, is designed to encourage additional Blue Bin recycling, increase recycling rates and put ...
US News digest everyday @ your email (Popularity: ): presstitles.com is a portal that searches and organizes US Newspapers and Magazines, to allow a richer experience on the part of the reader.We also guarantee direct access to the site of every publication, so that the visitor can subscribe the publication or interact in other ways.It covers all major newspapers from all states of USA, and more than 40 sections of top magazines.In our busy life schedule,we may find difficulty ...
The Conference Board Consumer Confidence Index(R) Edges Up (Popularity: ): The Conference Board Consumer Confidence Index®, which had declined in October, increased slightly in November. The Index now stands at 49.5 (1985=100), up from 48.7 in October. The Present Situation Index was virtually unchanged at 21.0 versus 21.1 last month. The Expectations Index increased to 68.5 from 67.0 in October.The Consumer Confidence Survey® is based on a representative sample of 5,000 U.S. households. The monthly survey is conducted for The ...
The Law Office of John H. Darrow, your personal injury lawyer in Seattle (Popularity: ): The Law Office of John H. Darrow, your Seattle area lawyer focusing on personal injury, commercial auto accident and car accident cases for over 20 years. John Darrow is a Seattle based attorney who has focused his entire career on ensuring people get a fair settlement from the insurance companies when faced with a personal injury, car accident or commercial auto accident claim.John H. Darrow is a 1986 graduate of ...

Press release home snapshot 

Related Business 
People Living With Cancer (Popularity: ): Patient information from the American Society of Clinical Oncology.
South Florida Radiation Oncology (SFRO) (Popularity: ): South Florida Radiation Oncology (SFRO), a cancer treatment center in Florida, has the most extensive radiation oncology, the most advanced cancer treatment options and the most personal cancer care in Florida. Get back to living your life. At South Florida Radiation Oncology our mission is to prevent and cure cancer through leading-edge cancer care and treatment. We can help you fight almost any type of cancer—so you can get back ...
Metastatic Pancreatic Cancer (Popularity: ): Information on metastatic pancreatic cancer and liver cancer including stages of pancreatic cancer, cause of it and life expectancy plus loads more. It is about 15 centimeters in length and is located between the stomach and the spine on the left side of the body. Pancreatic cancers spread rapidly.
Journal of Clinical Oncology (Popularity: ): Journal of the American Society of Clinical Oncology. Searchable archives as well as topical and issue indexes. Email alerts available.
Oncology Treatments India (Popularity: ): Kaizen is India most reputed medical tourism services provide Best Oncology, Cervical Cancer, Throat Cancer and Cancer Treatment in Delhi, India.
American Society for Therapeutic Radiology and Oncology (ASTRO) (Popularity: ): Medical society site for members and non-members of American Society for Therapeutic Radiology and Oncology providing current and updated information relating to radiation oncology including news releases.
American Radium Society (Popularity: ): promotes the study of cancer treatment and encourages liaison among medical specialists and allied scientists.
American Association for Cancer Research (Popularity: ): American Association for Cancer Research represents laboratory and clinical scientists engaged in basic, translational and clinical cancer research. AACR's mission is to prevent and cure cancer.
Bedford Breast Center (Popularity: ): Bedford breast center is a world-class facility dedicated to screening, early detection and surgeons who take into account the importance of aesthetics as well as curing disease. Whether you need routine screening or are concerned about breast pain or a complicated cancer diagnosis, we stand with you. Every step of the way.
American Society of Clinical Oncology (Popularity: ): The information provided by ASCO is extensive and aimed towards health professionals.